Get started
Author

Tobias Warger

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study
2017 · Thomas Berg, Karl-Georg Simon, et al. · Journal of Hepatology · 310
Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo
2006 · Tobias Warger, Philipp Osterloh, et al. · Blood · 241
Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function
2007 · Jan Kubach, Petra Lutter, et al. · Blood · 213
Cutting Edge: Priming of CTL by Transcutaneous Peptide Immunization with Imiquimod
2005 · Gerd Rechtsteiner, Tobias Warger, et al. · The Journal of Immunology · 152
Interaction of TLR2 and TLR4 Ligands with the N-terminal Domain of Gp96 Amplifies Innate and Adaptive Immune Responses
2006 · Tobias Warger, Nobert Hilf, et al. · Journal of Biological Chemistry · 135
PDF
Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice
2007 · Valeska Heib, Marc Becker, et al. · Blood · 115
Interferon-γ Induces Chronic Active Myocarditis and Cardiomyopathy in Transgenic Mice
2007 · Kurt Reifenberg, Hans-Anton Lehr, et al. · American Journal Of Pathology · 105
PDF
Initiation of adaptive immune responses by transcutaneous immunization
2007 · Tobias Warger, Hansjörg Schild, et al. · Immunology Letters · 53
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany
2015 · Jörg Petersen, Renate Heyne, et al. · Digestive Diseases and Sciences · 50
Glycoprotein 96–activated dendritic cells induce a CD8-biased T cell response
2005 · Sabina Rayo Ramirez, Harpreet Singh-Jasuja, et al. · Cell Stress and Chaperones · 39
Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection
2007 · Tobias Warger, Gerd Rechtsteiner, et al. · Clinical Reviews in Allergy & Immunology · 28
PDF
UV Exposure Boosts Transcutaneous Immunization and Improves Tumor Immunity: Cytotoxic T-Cell Priming through the Skin
2010 · Pamela Stein, Gerd Rechtsteiner, et al. · Journal of Investigative Dermatology · 25
PDF
O119 : Stopping tenofovir disoproxil fumarate (TDF) treatment after long term virologic suppression in HBeAg-negative CHB: Week 48 interim results from an ongoing randomized, controlled trial (“finite CHB”)
2015 · T. Berg, K.-G. Simon, et al. · Journal of Hepatology · 13
Precursor frequency can compensate for lower TCR expression in T cell competition during priming in vivo
2006 · Gerd Rechtsteiner, Tobias Warger, et al. · European Journal of Immunology · 9
768 Effectiveness of Tenofovir for Chronic Hepatitis B in Field Practice – 2 Year Interim Results From the Prospective German Multicenter Non-interventional Study (geminis)
2013 · J. Petersen, R. Heyne, et al. · Journal of Hepatology · 6
PDF
537 Tenofovir Df for Chronic Hepatitis B Patients in Field Practice - Results From the Geminis German Multicenter Observational Study
2012 · J. Petersen, R. Heyne, et al. · Journal of Hepatology · 5
O122 Effectiveness of Tenofovir Df for Chronic Hepatitis B in Field Practice – 3 Year Final Results From the Prospective German Multicenter Non-interventional Study
2014 · J. Petersen, R. Heyne, et al. · Journal of Hepatology · 4
Stopping Tenofovir Disoproxil Fumarate (TDF) treatment after long term virologic suppression in HBeAg-negative CHB: Week 48 interim results from an ongoing randomized, controlled trial („FINITE CHB“)
2015 · T Berg, K Simon, et al. · Zeitschrift für Gastroenterologie · 2
Integrated safety analysis of Sofosbuvir-based HCV treatment regimens from phase 3 studies
2014 · S Christensen, S Zeuzem, et al. · Zeitschrift für Gastroenterologie · 2
All oral fixed-dose combination Sofosbuvir/Ledipasvir with or without Ribavirin for 12 or 24 weeks in treatment-naive genotype 1 HCV-infected patients: the phase 3 ION-1 study
2014 · P Buggisch, T Göser, et al. · Zeitschrift für Gastroenterologie · 1
Early viral kinetics do not predict treatment outcome with sofosbuvir+ribavirin for 12 or 24 weeks in HCV genotype 2/3 patients in the valence trial
2014 · C Eisenbach, S Christensen, et al. · Zeitschrift für Gastroenterologie · 1
Wirksamkeit von Tenofovir (TDF) bei chronischer Hepatitis B (CHB) in der klinischen Praxis - 2 Jahres Daten der Deutschen Pprspektiven Multizentrischen nicht-Interventionellen Studie (NIS) „GEMINIS“
2013 · J Petersen, R Heyne, et al. · Zeitschrift für Gastroenterologie
Tenofovir DF bei chronischer Hepatitis B (CHB) in der klinischen Praxis – Ergebnisse der Nicht-Interventionellen Multizenterstudie (NIS) „GEMINIS“
2012 · J Petersen, R Heyne, et al. · Zeitschrift für Gastroenterologie
Charakterisierung der Therapie chronischer HBV Infektion (CHB) mit Tenofovir Disoproxil Fumarat (TDF) in der deutschen Behandlungspraxis – prospektive nicht-interventionelle Studie (NIS) „GEMINIS“
2011 · J Petersen, R Heyne, et al. · Zeitschrift für Gastroenterologie
Mastzellen als Bindeglied zwischen angeborener und adaptiver Immunität
2007 · V Heib, M Becker, et al. · Pneumologie
Works count: 27
Citation count: 1,509
H-index: 13
I10-index: 13
Year
Topic
Type